Covance expanded its facilities in Singapore for food manufacturers in the region. Manufacturers operating in Asia to export food to the U.S. will soon be able to send samples to a laboratory in Singapore. Chinese state media stated that the Singapore lab will initially focus on the testing of infant formula for release, stability and labeling data, and also include testing of food and health supplements. Joseph Herring, chairman and chief executive officer of Covance, said: “Testing here will reduce that testing time by 50 percent.”

Next month, Akaza, the provider of open source clinical trial software, expects to unveil a new version of its web-based electronic data capture software OpenClinica Research. The new version will include support for internationalization and localization. Tom Hickerson, OpenClinica’s senior project coordinator said: “The internationalization features in OpenClinica 2.2 will provide an easy-to-use general purpose infrastructure for running OpenClinica in any language.” The localization kit was largely developed through OpenClinica’s open source community by BAP Health Outcomes, a contract research organization based in Spain.

Image Solutions announced that its Tianjin, China office was granted ISO 9001:2000 certification by the International Organization for Standardization for meeting exacting quality management systems standards in all areas of operation, including electronic document processing services. Jinsoo Kim, president and chief executive officer of Image Solutions said: “Receiving recognition for our quality management processes from an organization with such stringent standards as ISO verifies ISI’s strong commitment to our customers.”

ChemDiv, a global chemistry-driven contract research organization (CRO), has announced that its Chemical Diversity Research Institute is undertaking a partnership with the following: Blokhin Russian Oncology Center of the Russian Academy of Medical Sciences; Oak Ridge National Laboratory; and the U.S. National Cancer Institute. The goal is to develop novel small molecule therapies for the prevention and treatment of prostate cancer. The partnership will operate under the auspices of The Global Initiatives for Proliferation Prevention Program.

The College of Nursing & Healthcare Innovation at the Arizona State University (ASU) has launched an interdisciplinary Center for Healthcare Innovation & Clinical Trials (CHI&CT). The center is in partnership with InnovationSpace, an ASU entrepreneurial joint venture. It includes the College of Design, the Ira A. Fulton College of Engineering, the W. P. Carey School of Business and Arizona Technology Enterprises (AzTE). Bernadette Melnyk, the college’s dean and a Distinguished Foundation Professor in Nursing, said: “It will attract scientists and health care practitioners who have innovative ideas for products to improve health care, but who need assistance in actualizing their ideas through design, clinical trial testing and taking their product to market.”

Have a news release? Send it to .(JavaScript must be enabled to view this email address).

d9A2t49mkex